Goldman Sachs cuts Abivax stake to 4.86%, below 5% threshold

ABVX•2026-11-05

Goldman Sachs’ indirect stake in Abivax fell below 5% on October 9, 2026, after an off-market share sale. It held 4,237,129 shares, representing 4.86% of capital and 4.79% of voting rights.

1. Stake falls below threshold

Goldman Sachs’ stake in Abivax fell below 5% on October 9, 2026, following an off-market share sale. Its indirect holding totaled 4,237,129 shares, representing 4.86% of capital; voting rights stood at 4.79%.

Sources

Goldman Sachs cuts Abivax stake to 4.86%, below 5% threshold

Docs

Goldman Sachs cuts Abivax stake to 4.86%, below 5% threshold

1. Stake falls below threshold

Related News

Morgan Stanley cuts Cisco Systems target price to $120 from $135

OpenText forecasts Q2 revenue of USD 1.26 billion to USD 1.29 billion

Installed Building Products Q3 revenue $808.4 million vs. IBES estimate $787.3 million

Sources

Goldman Sachs cuts Abivax stake to 4.86%, below 5% threshold

Agilon health to host virtual investor event on clinical strategy and technology platform

Aurora Cannabis management commentary cites higher adjusted SG&A as driver of Q2 fiscal 2027 adjusted EBITDA decline